アブカムでは最適な動作のために Google Chrome など最新ブラウザでの閲覧を推奨します。
A synthetic peptide corresponding to residues near the N-terminus of Human SOCS2
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
Our Abpromise guarantee covers the use of ab109245 in the following tested applications.
|WB||1/1000 - 1/10000. Predicted molecular weight: 22 kDa.|
|IP||1/10 - 1/100.|
|ICC/IF||1/100 - 1/250.|
ab109245 has not yet been referenced specifically in any publications.